Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALIGN TECHNOLOGY INCALGN · Entity 3488 | Director | May 20, 2026 | May 22, 2026 |
| ILLUMINA, INC.ILMN · Entity 3137 | Director | May 21, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALIGN TECHNOLOGY INC
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,723 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Exercise / conversion · Acquired 1,745 · Balance 10,723 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Exercise / conversion · Disposed 1,745 · Balance 0 F1: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,836 |
Reported balance
After 2026-05-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-20 · Grant · Acquired 1,836 · Balance 1,836 F2: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person.
F2: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date.
ILLUMINA, INC.
Report date May 21, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,535 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 2,072 · Balance 16,535 F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. |
| Common StockSEC Table I · non-derivative | IndirectReed-Siegel Revocable Trust | 4,006 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,006 |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NEVRO CORP
Report date April 03, 2025 · Filed April 03, 2025
Section 16 reporting ended · disclosed 2025-04-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-04-03 transaction · row 1
1 source rowRow 1 · 2025-04-03 · Disposition to issuer · Disposed 24,579 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. ("Globus") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus ("Merger Sub"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the "Effective Time"). F2: At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the "Merger Consideration"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2025-04-03 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2025-04-03 · Disposition to issuer · Disposed 7,382 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. ("Globus") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus ("Merger Sub"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the "Effective Time"). F2: At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the "Merger Consideration"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration. F3: Shares held by Bob Reed and Susan Siegel as trustees of the Reed-Siegel Revocable Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. ("Globus") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus ("Merger Sub"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the "Effective Time").
F2: At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the "Merger Consideration"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration.
F3: Shares held by Bob Reed and Susan Siegel as trustees of the Reed-Siegel Revocable Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 22, 2026 21:16 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 2,072 | $144.83 | $300,087.76 |
DisclosureSEC source: 0001110803-26-000120 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,535 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 20, 2026 Filed May 22, 2026 23:16 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 1,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-237340 · ownership.xml · derivative · entry 3 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,836 Underlying: Common Stock · 1,836 shares Expires not disclosed F2 · derivative.exercise_price: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F2 · derivative.exercise_date: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F2 · derivative.expiration_date: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. Read SEC document |
| May 20, 2026 Filed May 22, 2026 23:16 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 1,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-237340 · ownership.xml · derivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,745 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. F1 · derivative.exercise_date: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. F1 · derivative.expiration_date: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. Read SEC document |
| May 20, 2026 Filed May 22, 2026 23:16 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-237340 · ownership.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:14 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 1,745 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014209 · form4-05222025_090513.xml · derivative · entry 3 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,745 Underlying: Common Stock · 1,745 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the RSUs granted on May 21, 2025 will become vested on the earlier of (i) May 21, 2026 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F3 · derivative.expiration_date: 100% of the RSUs granted on May 21, 2025 will become vested on the earlier of (i) May 21, 2026 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:14 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 1,148 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014209 · form4-05222025_090513.xml · derivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,148 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock units ("RSUs") granted on May 22, 2024 vested on May 21, 2025 and shares were delivered to the Reporting Person. F2 · derivative.expiration_date: 100% of the restricted stock units ("RSUs") granted on May 22, 2024 vested on May 21, 2025 and shares were delivered to the Reporting Person. Read SEC document |
| May 21, 2025 Filed May 22, 2025 21:14 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-014209 · form4-05222025_090513.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:04 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 3,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015502 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,463 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. F2 · balance_after: In connection with Illumina's spin out of Grail, Inc., which was completed on June 24, 2024, all unvested equity award units were adjusted pursuant to Illumina's Amended and Restated 2015 Stock and Incentive Plan. Ms. Siegel's unvested RSUs were increased by 53 units as a result of such adjustment. Read SEC document |
| April 03, 2025 Filed Apr 3, 2025 16:30 UTC | NEVRO CORP NVRO · Entity 12422 | Disposition to issuerCommon Stock | 7,382 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-050473 · ownership.xml · nonDerivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. ("Globus") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus ("Merger Sub"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the "Effective Time"). F2 · price: At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the "Merger Consideration"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration. F3 · ownership.nature: Shares held by Bob Reed and Susan Siegel as trustees of the Reed-Siegel Revocable Trust. Read SEC document |
| April 03, 2025 Filed Apr 3, 2025 16:30 UTC | NEVRO CORP NVRO · Entity 12422 | Disposition to issuerCommon Stock | 24,579 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-050473 · ownership.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. ("Globus") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus ("Merger Sub"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the "Effective Time"). F2 · price: At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the "Merger Consideration"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 16:08 UTC | NEVRO CORP NVRO · Entity 12422 | GiftCommon Stock | 6,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-24-000366 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,579 F1 · kind: On June 25, 2024, the Reporting Person transferred 6,754 directly held shares to the Reed-Siegal Revocable Trust. F2 · balance_after: Includes 19,169 restricted stock units. Read SEC document |
| May 23, 2024 Filed May 28, 2024 18:58 UTC | NEVRO CORP NVRO · Entity 12422 | GrantCommon Stock | 19,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-24-000267 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,333 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 23, 2024 or (ii) the next Annual Meeting following May 23, 2024, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Includes 19,169 RSUs. Read SEC document |
| May 22, 2024 Filed May 24, 2024 20:20 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 1,148 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014479 · form4-05242024_080521.xml · derivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,148 Underlying: Common Stock · 1,148 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock units granted on May 22, 2024 will become vested on the earlier of (i) May 22, 2025 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. F2 · derivative.expiration_date: 100% of the restricted stock units granted on May 22, 2024 will become vested on the earlier of (i) May 22, 2025 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. Read SEC document |
| May 17, 2024 Filed May 21, 2024 23:22 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 1,029 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014028 · form4-05212024_110551.xml · derivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,029 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock units granted on May 17, 2023 became vested on May 17, 2024 and shares were delivered to the Reporting Person. F3 · derivative.expiration_date: 100% of the restricted stock units granted on May 17, 2023 became vested on May 17, 2024 and shares were delivered to the Reporting Person. Read SEC document |
| May 17, 2024 Filed May 21, 2024 23:22 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014028 · form4-05212024_110551.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The Form 4 filed by the Reporting Person on May 19, 2023 erroneously reported that the 1,114 shares received by her in the vesting of a restricted stock unit were disposed. The number of shares beneficially owned by the Reporting Person in this report includes those 1,114 shares. Read SEC document |
| May 16, 2024 Filed May 17, 2024 22:05 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 2,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015922 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,630 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 26, 2023 Filed May 31, 2023 21:01 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 1,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017241 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,008 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 25, 2023 Filed May 30, 2023 17:28 UTC | NEVRO CORP NVRO · Entity 12422 | GrantCommon Stock | 6,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-23-000080 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,164 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2023 or (ii) the next Annual Meeting following May 25, 2023, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Includes 7,381 RSUs. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:31 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 1,029 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031147 · doc4.xml · derivative · entry 3 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,029 Underlying: Common Stock · 1,029 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 17, 2023 will become vested on the earlier of (i) May 17, 2024 or (i) the date of the 2024 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 17, 2023 will become vested on the earlier of (i) May 17, 2024 or (i) the date of the 2024 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:31 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 1,114 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031147 · doc4.xml · derivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,114 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 18, 2022 became vested on May 17, 2023 and shares were delivered to reporting person. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 18, 2022 became vested on May 17, 2023 and shares were delivered to reporting person. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:31 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031147 · doc4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2022 Filed May 27, 2022 23:40 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 1,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015924 · form4.xml · nonDerivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,476 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:58 UTC | NEVRO CORP NVRO · Entity 12422 | GrantCommon Stock | 4,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-011886 · doc1.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,410 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 26, 2022 or (ii) the next Annual Meeting following May 26, 2022, subject to the Reporting Person's continued service to the issuer. F2 · balance_after: Includes 5,410 RSUs. Read SEC document |
| May 25, 2022 Filed May 27, 2022 23:40 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 352 | $242.40 | $85,324.80 |
DisclosureSEC source: 0001127602-22-015924 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,244 Read SEC document |
| May 18, 2022 Filed May 19, 2022 22:11 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 1,114 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030710 · doc4.xml · derivative · entry 3 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,114 Underlying: Common Stock · 1,114 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 18, 2022 will become vested on the earlier of (i) May 18, 2023 or (i) the date of the 2023 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 18, 2022 will become vested on the earlier of (i) May 18, 2023 or (i) the date of the 2023 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 18, 2022 Filed May 19, 2022 22:11 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 524 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030710 · doc4.xml · derivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 524 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 19, 2021 became vested on May 18, 2022 and shares were delivered to reporting person on such vest date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 19, 2021 became vested on May 18, 2022 and shares were delivered to reporting person on such vest date. Read SEC document |
| May 18, 2022 Filed May 19, 2022 22:11 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 524 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030710 · doc4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2021 Filed May 27, 2021 21:32 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018204 · form4.xml · nonDerivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,596 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:32 UTC | ILLUMINA, INC. ILMN · Entity 3137 | Tax withholdingCommon Stock | 385 | $397.09 | $152,879.65 |
DisclosureSEC source: 0001127602-21-018204 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,715 Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:09 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 524 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035060 · doc4.xml · derivative · entry 3 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 524 Underlying: Common Stock · 524 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 19, 2021 will become vested on the earlier of (i) May 19, 2022 or (i) the date of the 2022 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 19, 2021 will become vested on the earlier of (i) May 19, 2022 or (i) the date of the 2022 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:09 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 1,271 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035060 · doc4.xml · derivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,271 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 20, 2020 became vested on May 19, 2021 and shares were delivered to reporting person on such vest date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 20, 2020 became vested on May 19, 2021 and shares were delivered to reporting person on such vest date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:09 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035060 · doc4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 17:58 UTC | NEVRO CORP NVRO · Entity 12422 | GrantCommon Stock | 1,883 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-020667 · doc1.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,883 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on December 2 of each year, beginning December 2, 2021, subject to the Reporting Person's continued service to the issuer. F2 · balance_after: Includes 1,883 RSUs. Read SEC document |
| May 27, 2020 Filed May 28, 2020 22:15 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 963 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018088 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,100 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 20, 2020 Filed May 21, 2020 22:20 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 1,271 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031432 · doc4.xml · derivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,271 Underlying: Common Stock · 1,271 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 20, 2020 will become vested on the earlier of (i) May 20, 2021 or (i) the date of the 2021 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 20, 2020 will become vested on the earlier of (i) May 20, 2021 or (i) the date of the 2021 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 15, 2020 Filed May 19, 2020 22:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 921 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030670 · doc4.xml · derivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 15, 2019 became vested on May 15, 2020 and shares were delivered to reporting person on such vest date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 15, 2019 became vested on May 15, 2020 and shares were delivered to reporting person on such vest date. Read SEC document |
| May 15, 2020 Filed May 19, 2020 22:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantCommon Stock | 921 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030670 · doc4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,892 Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 01:19 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 1,100 | $275.00 | $302,500.00 |
DisclosureSEC source: 0001240363-20-000002 · primary_doc.xml · nonDerivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,971 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 7, 2019. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 01:19 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 300 | $270.00 | $81,000.00 |
DisclosureSEC source: 0001240363-20-000002 · primary_doc.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,071 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 7, 2019. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 00:12 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 300 | $260.05 | $78,015.00 |
DisclosureSEC source: 0001240363-20-000001 · primary_doc.xml · nonDerivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,371 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 7, 2019. Read SEC document |
| February 03, 2020 Filed Feb 6, 2020 00:12 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 300 | $257.50 | $77,250.00 |
DisclosureSEC source: 0001240363-20-000001 · primary_doc.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,671 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 7, 2019. Read SEC document |
| May 29, 2019 Filed May 30, 2019 21:43 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 1,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020256 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,137 F1 · security: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| May 15, 2019 Filed May 18, 2019 01:04 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Units · Derivative | 921 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000005 · primary_doc.xml · derivative · entry 3 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 921 Underlying: Common Stock · 921 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock F3 · derivative.exercise_date: 100% of the restricted stock unit will become vested on the earlier of (i) May 15, 2020 or (ii) the date of the 2020 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit will become vested on the earlier of (i) May 15, 2020 or (ii) the date of the 2020 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 15, 2019 Filed May 18, 2019 01:04 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Units · Derivative | 1,042 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000005 · primary_doc.xml · derivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 16, 2018 became vested on May 15, 2019 and shares were delivered to reporting person on that date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 16, 2018 became vested on May 15, 2019 and shares were delivered to reporting person on that date. Read SEC document |
| May 15, 2019 Filed May 18, 2019 01:04 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000005 · primary_doc.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 22:07 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 2,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-004592 · form4.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,839 F1 · shares: Grant of restricted stock units with 25% of the shares subject to the award vesting on each of the first, second, third and fourth anniversaries of the date of grant, subject to the awardee's continuing to be a service provider on such dates. Read SEC document |
| May 16, 2018 Filed May 18, 2018 21:16 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 1,042 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-18-000004 · primary_doc.xml · derivative · entry 3 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,042 Underlying: Common Stock · 1,042 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock. F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 16, 2018 will become vested on the earlier of (i) May 16, 2019 or (ii) the date of the 2019 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 16, 2018 will become vested on the earlier of (i) May 16, 2019 or (ii) the date of the 2019 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 16, 2018 Filed May 18, 2018 21:16 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 3,115 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-18-000004 · primary_doc.xml · derivative · entry 2 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,115 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock. F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 17, 2017 became vested on May 16, 2018 and shares were delivered to reporting person on that date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 17, 2017 became vested on May 16, 2018 and shares were delivered to reporting person on that date. Read SEC document |
| May 16, 2018 Filed May 18, 2018 21:16 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 3,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-18-000004 · primary_doc.xml · nonDerivative · entry 1 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2017 Filed May 18, 2017 23:22 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 3,115 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-17-000009 · primary_doc.xml · derivative · entry 3 SIEGEL SUSAN E · CIK 0001240363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,115 Underlying: Common Stock · 3,115 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock F3 · derivative.exercise_date: 100% of the restricted stock unit will become vested upon the earlier of (1) one year after the date of grant or (2) the date of issuer's annual meeting of stockholders to be held in 2018. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit will become vested upon the earlier of (1) one year after the date of grant or (2) the date of issuer's annual meeting of stockholders to be held in 2018. Shares will be delivered to reporting person on the vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.